Read article – Quotes Steven Woloshin, professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice, in an article that examines America’s reliance on pharmaceuticals, and the role that marketing companies play in encouraging the consumption of pharmaceuticals. “Low T is a marketing term intended to sell testosterone as a kind of fountain of youth,” says Woloshin. For most men, he says, testosterone “declines naturally with age,” and research shows that taking drugs to compensate has “little or no benefit” and “some serious risks.”
Read article – An opinion piece by Reza Hessabi, Geisel ’20, in which he discusses his experience working as a field organizer for President Obama’s re-election campaign and how he saw people’s lives changed for the better with the Affordable Care Act’s passing.
Read article – Quotes Lisa Marsch, director of the Center for Technology and Behavioral Health (CTBH) and professor of psychiatry and of the Dartmouth Institute for Health Policy and Clinical Practice, about how she and additional colleagues released a study in June that pointed to Lawrence, Mass., as a major gateway for the fentanyl ravaging New Hampshire. Marsch, who led the study, said the sudden shift from heroin to fentanyl has been startling. “That’s what people want now,” says Marsch. “They want this more potent product.
Read article – As a guest on “Take Care,” Elijah Stommel, professor of neurology, discusses recent research he conducted that found a possible link between mercury in fish and ALS.
Read article – Cites a 2008 comparative study conducted by Brenda Sirovich, associate professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy & Clinical Practice, that compared physicians in cities with low costs of care and high costs of care. Sirovich found that physicians in cities with low costs of care typically called patients back less and utilized many less tests to confirm their diagnosis when compared to their higher-spending region counterparts, and did this without compromising the quality of care.
Read article – An article that mentions that the Geisel School of Medicine is part of the National Transformation Network, which is working to develop a curriculum for medical schools focused on three components: character, competence and caring. Other participating schools include the Mayo Clinic School of Medicine, UCSF School of Medicine, Vanderbilt University School of Medicine and the University of Wisconsin-Madison School of Medicine and Public Health. Website required registration.
Read article – Quotes David Leib, professor of microbiology and immunology and adjunct professor of biology, about a new study he conducted that investigated if herpes simplex virus (HSV) antibodies made after infection with genital herpes could protect unborn children or babies exposed to HSV at birth.
Read article – Quotes Ira Byock, active emeritus professor of medicine and of community and family medicine, in an article examining reactions to the use of war metaphors in response to the news of Sen. John McCain’s brain tumor diagnosis. “I’d say first and foremost let’s all lighten up. … It’s just a metaphor, and metaphors have value, but they’re not a substitute for the reality,” says Byock. “The reality is we’re all mortal and we need to be gentle and loving with ourselves and with one another.”
Read article – Quotes Anna Tosteson, the James J. Carroll Professor of Oncology and professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice; about the how the Breast Cancer Surveillance Consortium (BCSC) has received a $17 million grant renewal from the National Cancer Institute to study the effectiveness of digital mammography, digital breast tomosynthesis and breast MRI as breast screening tools. Tosteson, who is a co-leader of consortium’s efforts, commented on why BCSC’s work is so crucial.
Read article – Article quotes H. Gilbert Welch, professor of medicine and of the Dartmouth Institute for Health Policy and Clinical Practice, and professor of economics, about a new device called AliveCor, which can make it easier for doctors to monitor and analyze blood pressure, weight and activity levels. “It’s a two-tailed problem,” says Welch. “More medical care may help some and may hurt others. The key question is who are the patients who will be subjected to this monitoring. If the device is confined to a genuinely high-risk group who are already experiencing frequent symptoms and receiving multiple visits and multiple EKGs, it might be very helpful.”